Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

SpringWorks Therapeutics
1 program
MirdametinibN/ASmall Molecule1 trial
Active Trials
NCT05028166Available

Clinical Trials (1)

NCT05028166SpringWorks TherapeuticsMirdametinib

Individual Patient Compassionate Use of Mirdametinib

N/AAvailable

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space